Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Primo Brands Corporation Class A Common Stock (PRMB) vs UnitedHealth Group Inc (UNH) Price & Performance

Primo Brands Corporation Class A Common StockTrade
UnitedHealth Group IncTrade

Price performance (Past 24H)

Key statistics

Primo Brands Corporation Class A Common Stock vs UnitedHealth Group Inc — how do they compare? Primo Brands Corporation Class A Common Stock trades at $18.76 (market cap $6.84B), while UnitedHealth Group Inc trades at $399.54 (market cap $339.08B). The key difference: UnitedHealth Group Inc is far larger — about 49.6× Primo Brands Corporation Class A Common Stock's market cap, and Primo Brands Corporation Class A Common Stock pays the higher dividend (2.54%). Which is the better fit depends on your goals — on Pluang, investors hold Primo Brands Corporation Class A Common Stock for 0 Days and UnitedHealth Group Inc for 98 Days on average.

PRMBUNH
Market Cap
$6.84B$339.08B
Volume
2,864,59412,648,635
Sector
Consumer StaplesHealth
52-Week High
$25.39$436.35
52-Week Low
$14.46$259.02
Typical Hold Time
0 Days98 Days
Enterprise Value
$12.17B$380.94B
Dividend Yield
2.54%2.46%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Primo Brands Corporation Class A Common Stock

PRMB trades at $18.9, down 1.46% on the day, with a neutral technical signal and key support/resistance clustered around $19. The company reported Q2 2026 EPS of $0.37, beating expectations, and shows improving revenue and net income trends for 2026. Recent news highlights expansion with a new factory opening and strong premium water sales growth, supporting a positive analyst consensus.

The outlook is positive, driven by sales momentum and capacity expansion, but risks include thin net margins and high P/E ratio. With 80% of analysts rating it Buy and a consensus price target of $28.50, the stock offers significant upside potential if execution continues, though margin pressure remains a key watchpoint.

UnitedHealth Group Inc

UnitedHealth Group (UNH) trades at $378.52, down 0.21% on the day, with strong technical momentum showing a bullish moving average signal. The company demonstrates robust fundamentals with consistent earnings beats in recent quarters, including Q3 2026 EPS of $4.69 beating expectations of $4.14. Revenue growth remains solid at $447.57B for 2025, though net margins have compressed to 3.14%. Recent developments include strategic moves with TPG for WellMed operations and continued AI investments in Optum Insight.

UNH presents a compelling investment case with 82.7% analyst buy ratings and a $470.11 consensus price target representing 24% upside. The company's Medicare Advantage strength and Optum improvements support growth, though regulatory scrutiny and medical cost pressures remain key risks. Strong institutional ownership and Michael Burry's recent call option position signal confidence in the turnaround story.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

PRMB
100% Buy0% Sell
Avg holding period · 0 Days
UNH
30% Buy70% Sell
Avg holding period · 98 Days

Top news

Latest headlines on both assets

About Primo Brands Corporation Class A Common Stock

Primo Brands Corporation is a branded beverage company that produces and distributes packaged and purified water, water dispensers, and filtration equipment across North America, under brands including Poland Spring, Pure Life, Arrowhead, and Primo Water.

Read more on PRMB →

About UnitedHealth Group Inc

UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.

Read more on UNH →